Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2010

Open Access 01-12-2010 | Research

Health-related quality of life in diabetes: The associations of complications with EQ-5D scores

Authors: Oddvar Solli, Knut Stavem, IS Kristiansen

Published in: Health and Quality of Life Outcomes | Issue 1/2010

Login to get access

Abstract

Background

The aim of this study was to describe how diabetes complications influence the health-related quality of life of individuals with diabetes using the individual EQ-5D dimensions and the EQ-5D index.

Methods

We mailed a questionnaire to 1,000 individuals with diabetes type 1 and 2 in Norway. The questionnaire had questions about socio-demographic characteristics, use of health care, diabetes complications and finally the EQ-5D descriptive system. Logistic regressions were used to explore determinants of responses in the EQ-5D dimensions, and robust linear regression was used to explore determinants of the EQ-5D index.

Results

In multivariate analyses the strongest determinants of reduced MOBILITY were neuropathy and ischemic heart disease. In the ANXIETY/DEPRESSION dimension of the EQ-5D, "fear of hypoglycaemia" was a strong determinant. For those without complications, the EQ-5D index was 0.90 (type 1 diabetes) and 0.85 (type 2 diabetes). For those with complications, the EQ-5D index was 0.68 (type 1 diabetes) and 0.73 (type 2 diabetes). In the linear regression the factors with the greatest negative impact on the EQ-5D index were ischemic heart disease (type 1 diabetes), stroke (both diabetes types), neuropathy (both diabetes types), and fear of hypoglycaemia (type 2 diabetes).

Conclusions

The EQ-5D dimensions and the EQ-5D seem capable of capturing the consequences of diabetes-related complications, and such complications may have substantial impact on several dimensions of health-related quality of life (HRQoL). The strongest determinants of reduced HRQoL in people with diabetes were ischemic heart disease, stroke and neuropathy.
Literature
1.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H: Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27: 1047–1053. 10.2337/diacare.27.5.1047PubMedCrossRef Wild S, Roglic G, Green A, Sicree R, King H: Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27: 1047–1053. 10.2337/diacare.27.5.1047PubMedCrossRef
2.
go back to reference Grandy S, Fox K: EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Health and Quality of Life Outcomes 2008, 6: 18. 10.1186/1477-7525-6-18PubMedCentralPubMedCrossRef Grandy S, Fox K: EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Health and Quality of Life Outcomes 2008, 6: 18. 10.1186/1477-7525-6-18PubMedCentralPubMedCrossRef
3.
go back to reference Holmes J, McGill S, Kind P, Bottomley J, Gillam S, Murphy M: Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health 2000,3(Suppl 1):47–51. 10.1046/j.1524-4733.2000.36028.xPubMedCrossRef Holmes J, McGill S, Kind P, Bottomley J, Gillam S, Murphy M: Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health 2000,3(Suppl 1):47–51. 10.1046/j.1524-4733.2000.36028.xPubMedCrossRef
4.
go back to reference Koopmanschap M: Coping with Type II diabetes: the patient's perspective. Diabetologia 2002, 45: S18-S22.PubMedCrossRef Koopmanschap M: Coping with Type II diabetes: the patient's perspective. Diabetologia 2002, 45: S18-S22.PubMedCrossRef
5.
go back to reference Wexler D, Grant R, Wittenberg E, Bosch J, Cagliero E, Delahanty L, et al.: Correlates of health-related quality of life in type 2 diabetes. Diabetologia 2006, 49: 1489–1497. 10.1007/s00125-006-0249-9PubMedCrossRef Wexler D, Grant R, Wittenberg E, Bosch J, Cagliero E, Delahanty L, et al.: Correlates of health-related quality of life in type 2 diabetes. Diabetologia 2006, 49: 1489–1497. 10.1007/s00125-006-0249-9PubMedCrossRef
6.
go back to reference Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R: The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999, 8: 79–91. 10.1023/A:1026485130100PubMedCrossRef Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R: The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999, 8: 79–91. 10.1023/A:1026485130100PubMedCrossRef
7.
go back to reference Fitzgerald JT, Davis WK, Connell CM, Hess GE, Funnell MM, Hiss RG: Development and validation of the Diabetes Care Profile. Eval Health Prof 1996, 19: 208–230. 10.1177/016327879601900205PubMedCrossRef Fitzgerald JT, Davis WK, Connell CM, Hess GE, Funnell MM, Hiss RG: Development and validation of the Diabetes Care Profile. Eval Health Prof 1996, 19: 208–230. 10.1177/016327879601900205PubMedCrossRef
8.
go back to reference Hirsch A, Bartholomae C, Volmer T: Dimensions of quality of life in people with non-insulin-dependent diabetes. Quality of Life Research 2000, 9: 207–218. 10.1023/A:1008959810698PubMedCrossRef Hirsch A, Bartholomae C, Volmer T: Dimensions of quality of life in people with non-insulin-dependent diabetes. Quality of Life Research 2000, 9: 207–218. 10.1023/A:1008959810698PubMedCrossRef
9.
go back to reference Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30: 473–483. 10.1097/00005650-199206000-00002PubMedCrossRef Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30: 473–483. 10.1097/00005650-199206000-00002PubMedCrossRef
10.
go back to reference EuroQol Group: EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16: 199–208. 10.1016/0168-8510(90)90421-9CrossRef EuroQol Group: EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16: 199–208. 10.1016/0168-8510(90)90421-9CrossRef
11.
go back to reference Sintonen H: [Health-related quality of life measures]. Sairaanhoitaja 1993, 17–19. Sintonen H: [Health-related quality of life measures]. Sairaanhoitaja 1993, 17–19.
12.
go back to reference Furlong WJ, Feeny DH, Torrance GW, Barr RD: The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001, 33: 375–384. 10.3109/07853890109002092PubMedCrossRef Furlong WJ, Feeny DH, Torrance GW, Barr RD: The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001, 33: 375–384. 10.3109/07853890109002092PubMedCrossRef
13.
go back to reference Horsman J, Furlong W, Feeny D, Torrance G: The Health Utilities Index (HUI(R)): concepts, measurement properties and applications. Health and Quality of Life Outcomes 2003, 1: 54. 10.1186/1477-7525-1-54PubMedCentralPubMedCrossRef Horsman J, Furlong W, Feeny D, Torrance G: The Health Utilities Index (HUI(R)): concepts, measurement properties and applications. Health and Quality of Life Outcomes 2003, 1: 54. 10.1186/1477-7525-1-54PubMedCentralPubMedCrossRef
14.
go back to reference Brazier J, Roberts J, Deverill M: The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics 2002, 21: 271–292. 10.1016/S0167-6296(01)00130-8PubMedCrossRef Brazier J, Roberts J, Deverill M: The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics 2002, 21: 271–292. 10.1016/S0167-6296(01)00130-8PubMedCrossRef
15.
go back to reference Torrance GW, Thomas WH, Sackett DL: A utility maximization model for evaluation of health care programs. Health Serv Res 1972, 7: 118–133.PubMedCentralPubMed Torrance GW, Thomas WH, Sackett DL: A utility maximization model for evaluation of health care programs. Health Serv Res 1972, 7: 118–133.PubMedCentralPubMed
16.
go back to reference Klarman HEPh, Francis JO, Rosenthal GDP: Cost Effectiveness Analysis Applied to the Treatment of Chronic Renal Disease. [Article]. Medical Care 1968, 6: 48–54. 10.1097/00005650-196801000-00005CrossRef Klarman HEPh, Francis JO, Rosenthal GDP: Cost Effectiveness Analysis Applied to the Treatment of Chronic Renal Disease. [Article]. Medical Care 1968, 6: 48–54. 10.1097/00005650-196801000-00005CrossRef
17.
go back to reference Glasziou P, Alexander J, Beller E, Clarke P, the ADVANCE Collaborative Group: Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health and Quality of Life Outcomes 2007, 5: 21. 10.1186/1477-7525-5-21PubMedCentralPubMedCrossRef Glasziou P, Alexander J, Beller E, Clarke P, the ADVANCE Collaborative Group: Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health and Quality of Life Outcomes 2007, 5: 21. 10.1186/1477-7525-5-21PubMedCentralPubMedCrossRef
18.
go back to reference Dolan P: Modeling valuations for EuroQol health states. Med Care 1997, 35: 1095–1108. 10.1097/00005650-199711000-00002PubMedCrossRef Dolan P: Modeling valuations for EuroQol health states. Med Care 1997, 35: 1095–1108. 10.1097/00005650-199711000-00002PubMedCrossRef
19.
go back to reference Speight J, Reaney MD, Barnard KD: Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes. Diabet Med 2009, 26: 315–327. 10.1111/j.1464-5491.2009.02682.xPubMedCrossRef Speight J, Reaney MD, Barnard KD: Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes. Diabet Med 2009, 26: 315–327. 10.1111/j.1464-5491.2009.02682.xPubMedCrossRef
20.
go back to reference Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group Diabetes Care 1999, 22: 1125–1136. 10.2337/diacare.22.7.1125 Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group Diabetes Care 1999, 22: 1125–1136. 10.2337/diacare.22.7.1125
21.
go back to reference Matza LS, Boye KS, Yurgin N, Brewster-Jordan J, Mannix S, Shorr JM, et al.: Utilities and disutilities for type 2 diabetes treatment-related attributes. Qual Life Res 2007, 16: 1251–1265. 10.1007/s11136-007-9226-0PubMedCrossRef Matza LS, Boye KS, Yurgin N, Brewster-Jordan J, Mannix S, Shorr JM, et al.: Utilities and disutilities for type 2 diabetes treatment-related attributes. Qual Life Res 2007, 16: 1251–1265. 10.1007/s11136-007-9226-0PubMedCrossRef
22.
go back to reference Dennett SL, Boye KS, Yurgin NR: The impact of body weight on patient utilities with or without type 2 diabetes: a review of the medical literature. Value Health 2008, 11: 478–486. 10.1111/j.1524-4733.2007.00260.xPubMedCrossRef Dennett SL, Boye KS, Yurgin NR: The impact of body weight on patient utilities with or without type 2 diabetes: a review of the medical literature. Value Health 2008, 11: 478–486. 10.1111/j.1524-4733.2007.00260.xPubMedCrossRef
23.
go back to reference Burstrom K, Johannesson M, Diderichsen F: Swedish population health-related quality of life results using the EQ-5D. Qual Life Res 2001, 10: 621–635. 10.1023/A:1013171831202PubMedCrossRef Burstrom K, Johannesson M, Diderichsen F: Swedish population health-related quality of life results using the EQ-5D. Qual Life Res 2001, 10: 621–635. 10.1023/A:1013171831202PubMedCrossRef
24.
go back to reference Norinder AGPK: Estimating Danish EuroQol tariffs using the Time Trade off (TTO) and Visula Analogue Scale (VAS) Methods. In Proceedings of the 18th Plenary Meeting of the EuroQol Group Edited by: Roos P. 2002, 257–292. Norinder AGPK: Estimating Danish EuroQol tariffs using the Time Trade off (TTO) and Visula Analogue Scale (VAS) Methods. In Proceedings of the 18th Plenary Meeting of the EuroQol Group Edited by: Roos P. 2002, 257–292.
25.
go back to reference Nord E: EuroQol ® : health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy 1991, 18: 25–36. 10.1016/0168-8510(91)90141-JPubMedCrossRef Nord E: EuroQol ® : health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy 1991, 18: 25–36. 10.1016/0168-8510(91)90141-JPubMedCrossRef
Metadata
Title
Health-related quality of life in diabetes: The associations of complications with EQ-5D scores
Authors
Oddvar Solli
Knut Stavem
IS Kristiansen
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2010
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-8-18

Other articles of this Issue 1/2010

Health and Quality of Life Outcomes 1/2010 Go to the issue